Fort Myers, Fla., April 20, 2021 (GLOBE NEWSWIRE) -- Pareshkumar Patel, MD, medical oncologist with Florida Cancer Specialists & Research Institute (FCS), is the recipient of the Florida Society of Clinical Oncology (FLASCO) 2021 Advocate of the Year Award. The recognition was announced at the FLASCO Business of Oncology Summit & Spring Session held last week in Kissimmee, FL.
“Dr. Patel has served FLASCO in so many ways it would be impossible to begin to list them all,” said FLASCO President Dr. Luis E. Raez in presenting the award. “His tireless efforts are greatly appreciated.” Dr. Patel has served as FLASCO Legislative Committee Chair since 2018. In this leadership role he helps foster relationships with legislators and key policy makers, advocating on behalf of cancer patients and providers and serving as an expert resource on oncology issues.
“In addition to caring for patients at our FCS clinic locations in Tallahassee, FL, Dr. Patel works tirelessly to ensure access to cancer care throughout Florida and across the U.S. through numerous advocacy efforts,” said FCS Chief Executive Officer Nathan H. Walcker.
FCS President & Managing Physician Dr. Lucio Gordan said, “Dr. Patel has been steadfast in his efforts on behalf of cancer patients and community oncology providers. This recognition by his peers is well deserved.”
Dr. Patel attended B.J. Medical College Pune, Maharashtra, India and graduated with First Class Honors. He completed his residency in Internal Medicine at Jersey Shore Medical Center in Neptune, NJ followed by fellowships in Hospice and Palliative Care and Hematology and Oncology. Virginia Commonwealth University Health System in Richmond, VA. He is quadruple Board Certified in Medical Oncology, Hematology, Internal Medicine, and Hospice and Palliative Care.
###
About Florida Cancer Specialists & Research Institute
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. Over the past 5 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, MD Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies, and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians, and staff.
*Prior to approval
Attachment